Global Levosulpiride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Levosulpiride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Levosulpiride is a substituted benzamide antipsychotic.
Levosulpiride report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Levosulpiride market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Tablet and Capsule are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Levosulpiride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Levosulpiride key manufacturers include Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical, New Donghai Pharmaceutical, Suzhou Chenghe Pharmaceutical & Chemical and Harbin Gloria Pharmaceuticals, etc. Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical are top 3 players and held % sales share in total in 2022.
Levosulpiride can be divided into Above 98% and Below 98%, etc. Above 98% is the mainstream product in the market, accounting for % sales share globally in 2022.
Levosulpiride is widely used in various fields, such as Tablet, Capsule and Other,, etc. Tablet provides greatest supports to the Levosulpiride industry development. In 2022, global % sales of Levosulpiride went into Tablet filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Levosulpiride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sun Pharmaceutical Industries
Vasoya Industries
Bona Chemical
New Donghai Pharmaceutical
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Segment by Type
Above 98%
Below 98%
Tablet
Capsule
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Levosulpiride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Levosulpiride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Levosulpiride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Levosulpiride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Levosulpiride introduction, etc. Levosulpiride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Levosulpiride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Levosulpiride report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Levosulpiride market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Tablet and Capsule are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Levosulpiride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Levosulpiride key manufacturers include Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical, New Donghai Pharmaceutical, Suzhou Chenghe Pharmaceutical & Chemical and Harbin Gloria Pharmaceuticals, etc. Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical are top 3 players and held % sales share in total in 2022.
Levosulpiride can be divided into Above 98% and Below 98%, etc. Above 98% is the mainstream product in the market, accounting for % sales share globally in 2022.
Levosulpiride is widely used in various fields, such as Tablet, Capsule and Other,, etc. Tablet provides greatest supports to the Levosulpiride industry development. In 2022, global % sales of Levosulpiride went into Tablet filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Levosulpiride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sun Pharmaceutical Industries
Vasoya Industries
Bona Chemical
New Donghai Pharmaceutical
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Segment by Type
Above 98%
Below 98%
Segment by Application
Tablet
Capsule
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Levosulpiride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Levosulpiride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Levosulpiride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Levosulpiride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Levosulpiride introduction, etc. Levosulpiride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Levosulpiride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.